{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fthebrief-health.simplecast.com%2Fepisodes%2Fpromising-prostate-cancer-therapy-u37SoeNk","width":444,"version":"1.0","type":"rich","title":"Promising Prostate Cancer Therapy","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/90af2279-f7d9-426f-bdb6-cb4a4a221358/e73b2da8-efa4-49ef-98e2-a9f59a227a12/thebriefhealth-square-logo-white-background.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/8e4c11f4-156b-42d6-8618-ada27b7782e2\" height=\"200\" width=\"100%\" title=\"Promising Prostate Cancer Therapy\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies."}